CSIMarket
 

Cryoport inc   (NASDAQ: CYRX)

Cryoport Inc 's

Competitiveness




 

CYRX Sales vs. its Competitors Q1 2026



Comparing the current results to its competitors, Cryoport Inc reported Revenue increase in the 1 quarter 2026 by 16.47 % year on year.
The sales growth was above Cryoport Inc 's competitors' average revenue growth of 6.46 %, achieved in the same quarter.

List of CYRX Competitors





Revenue Growth Comparisons




Net Income Comparison


Cryoport inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 8 %

<<  CYRX Stock Performance Comparisons


Cryoport Inc 's Comment on Competition and Industry Peers


Our products and services are sold into a rapidly growing segment of the logistics industry focused on the temperature sensitive packaging and shipping of biological materials. Expenditures for “value added” packaging for frozen transport have been increasing for the past several years and, due in part to continued globalization, are expected to continue to increase even more in the future as more domestic and international biotechnology firms introduce pharmaceutical products that require continuous refrigeration at cryogenic temperatures. We believe this will require a greater dependence on passively controlled temperature transport systems (i.e., systems having no external power source). In addition, we expect that industry standards and regulations will be introduced globally, requiring more comprehensive tracking and validation of shipping temperatures.

We believe that growth in the following markets has resulted in the need for increased reliability, efficiencies and greater flexibility in the temperature sensitive segment of the logistics market:

· cell-based therapies

· gene and stem cell biotechnology

· cell lines

· vaccine production

· commercial drug product distribution

· clinical trials, including transport of tissue culture samples

· diagnostic specimens

· infectious sample materials

· inter/intra-laboratory diagnostic testing

· temperature-sensitive specimens

· biological samples, in general

· environmental sampling

· IVF

· animal husbandry

Many of the biological products in these above markets require transport in a frozen state as well as the need for shipping containers which have the ability to maintain a frozen, cryogenic environment (e.g., minus 150° Celsius) for a period ranging from two to ten days (depending on the distance and mode of shipment). These products include stem cells, semen, embryo, tissue, tissue cultures, cultures of viruses and bacteria, enzymes, DNA materials, vaccines and certain pharmaceutical products.

One of the integral parts of our solutions are our Cryoport Express® Shippers that are based on a liquid nitrogen dry vapor technology. The following paragraphs compare our shippers with dry ice and liquid nitrogen shipping methods. Our solutions integrate the Cryoport Express® Shippers with our CryoportalTM logistics software platform and our cold chain logistics know-how that are comprehensive and tailored to client requirements.




  

Overall company Market Share Q1 2026

Overall company sales advanced by 16.47 % Cryoport Inc outperformed its competitors in this segment and improved market share, to approx. 0.37 %.
<<  More on CYRX Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Cryoport inc




Biolife Solutions Inc
Share Performance



-0.32%
Over The Past 5 Days



Biolife Solutions Inc
Profile

Biolife Solutions Inc's business model revolves around providing biopreservation tools and services to the biotech and pharmaceutical industries.

More about Biolife Solutions Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 1,825.626 mill. $ 99.673 mill. $ -2.961 mill.


Charles River Laboratories International inc
Share Performance



+78.75%
One Year



Charles River Laboratories International inc
Profile

Charles River Laboratories International Inc is a contract research organization (CRO) that provides essential services and support to the pharmaceutical, biotech, and medical device industries. They offer a wide range of research models, drug discovery and development services, safety assessments, and laboratory animal medicine to assist in the preclinical and clinical stages of drug development.

More about Charles River Laboratories International inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 14,109.636 mill. $ 4,027.044 mill. $ -182.843 mill.


Catalent Inc
Share Performance



+40.91%
This Year



Catalent Inc
Profile

Catalent Incs business model centers around offering comprehensive development and delivery solutions to pharmaceutical, biotechnology, and consumer health companies. By providing a diverse array of services such as drug development, manufacturing, packaging, and supply chain management, they aim to expedite the market entry of innovative and life-saving products for their clients.

More about Catalent Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 11,553.360 mill. $ 4,422.000 mill. $ -413.000 mill.


Evotec Se
Share Performance



-0.53%
Over The Past 5 Days



Evotec Se
Profile

Evotec SE is a German drug discovery and development company that operates on a contract research organization (CRO) business model. They offer a comprehensive range of services to pharmaceutical and biotechnology companies, including target identification and validation, hit identification, and lead optimization. Through collaborations and partnerships, Evotec aims to accelerate the discovery and development of new drugs and therapies.

More about Evotec Se's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 166.924 mill. $ 882.978 mill. $ -115.939 mill.


Thermo Fisher Scientific Inc
Share Performance



+7.45%
30 Days



Thermo Fisher Scientific Inc
Profile

Thermo Fisher Scientific Inc operates as a global leader in scientific research and services by delivering an extensive range of high-quality scientific instruments, reagents, consumables, and software solutions tailored to industries such as healthcare, pharmaceuticals, biotechnology, academia, and government. The company enhances its value proposition through a comprehensive suite of services, including laboratory outsourcing, scientific consulting, and data analysis, which help streamline research and development processes for its customers. By leveraging advanced technology and deep industry expertise, Thermo Fisher empowers researchers and organizations to drive innovation and accelerate scientific discovery.

More about Thermo Fisher Scientific Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 228,944.100 mill. $ 46,336.000 mill. $ 6,989.000 mill.

1 more competitors available

Sign in to see all competitors

Sources: Cryoport inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Cryoport inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.